Val S. Goodfellow

958 total citations
28 papers, 802 citations indexed

About

Val S. Goodfellow is a scholar working on Molecular Biology, Nutrition and Dietetics and Endocrine and Autonomic Systems. According to data from OpenAlex, Val S. Goodfellow has authored 28 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Nutrition and Dietetics and 12 papers in Endocrine and Autonomic Systems. Recurrent topics in Val S. Goodfellow's work include Biochemical Analysis and Sensing Techniques (13 papers), Regulation of Appetite and Obesity (12 papers) and Receptor Mechanisms and Signaling (8 papers). Val S. Goodfellow is often cited by papers focused on Biochemical Analysis and Sensing Techniques (13 papers), Regulation of Appetite and Obesity (12 papers) and Receptor Mechanisms and Signaling (8 papers). Val S. Goodfellow collaborates with scholars based in United States, Czechia and Germany. Val S. Goodfellow's co-authors include John Saunders, Petra Hirsova, Gregory J. Gores, Nathan W. Werneburg, Samar H. Ibrahim, Kyoko Tomita, Harmeet Malhi, Steven F. Bronk, Stephen A. Harrison and Brian Dyck and has published in prestigious journals such as Journal of Neuroscience, Circulation Research and Hepatology.

In The Last Decade

Val S. Goodfellow

28 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Val S. Goodfellow United States 17 371 196 194 168 146 28 802
Yousang Hwang United States 15 757 2.0× 219 1.1× 265 1.4× 48 0.3× 130 0.9× 19 1.1k
Lihu Yang United States 19 501 1.4× 101 0.5× 144 0.7× 62 0.4× 449 3.1× 39 1.1k
Geeta Patel United Kingdom 18 288 0.8× 59 0.3× 42 0.2× 40 0.2× 224 1.5× 45 732
Feroze Ujjainwalla United States 16 299 0.8× 65 0.3× 49 0.3× 33 0.2× 523 3.6× 28 952
Barbara J. Palazuk United States 10 421 1.1× 24 0.1× 61 0.3× 182 1.1× 71 0.5× 10 683
K. A. NEWLANDER United States 7 197 0.5× 53 0.3× 127 0.7× 16 0.1× 43 0.3× 9 543
Jinhai Gao United States 10 524 1.4× 44 0.2× 24 0.1× 82 0.5× 57 0.4× 18 907
Gene F. Tutwiler United States 16 492 1.3× 45 0.2× 50 0.3× 54 0.3× 55 0.4× 46 1.1k
Janet Cheetham United States 17 480 1.3× 137 0.7× 60 0.3× 9 0.1× 68 0.5× 28 915
Huiqiang Zhou United States 14 309 0.8× 57 0.3× 59 0.3× 25 0.1× 200 1.4× 21 540

Countries citing papers authored by Val S. Goodfellow

Since Specialization
Citations

This map shows the geographic impact of Val S. Goodfellow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Val S. Goodfellow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Val S. Goodfellow more than expected).

Fields of papers citing papers by Val S. Goodfellow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Val S. Goodfellow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Val S. Goodfellow. The network helps show where Val S. Goodfellow may publish in the future.

Co-authorship network of co-authors of Val S. Goodfellow

This figure shows the co-authorship network connecting the top 25 collaborators of Val S. Goodfellow. A scholar is included among the top collaborators of Val S. Goodfellow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Val S. Goodfellow. Val S. Goodfellow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butkovich, Laura M., Joshua M. Bradner, Jianjun Chang, et al.. (2019). The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss. Experimental Neurology. 318. 157–164. 10 indexed citations
2.
Zhang, Gang, Dongwei Guo, Prasanta K. Dash, et al.. (2015). The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. Nanomedicine Nanotechnology Biology and Medicine. 12(1). 109–122. 24 indexed citations
3.
Ibrahim, Samar H., Petra Hirsova, Kyoko Tomita, et al.. (2015). Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology. 63(3). 731–744. 201 indexed citations
4.
Marker, Daniel F., Marie‐Ève Tremblay, Joseph Barbieri, et al.. (2013). The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders. Journal of Neuroscience. 33(24). 9998–10010. 50 indexed citations
5.
Rowbottom, Martin W., Mingzhu Zhang, Brian Dyck, et al.. (2007). Synthesis and structure–activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Bioorganic & Medicinal Chemistry Letters. 17(8). 2171–2178. 8 indexed citations
6.
Kiankarimi, Mehrak, Martin W. Rowbottom, Dongpei Wu, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2. Bioorganic & Medicinal Chemistry Letters. 16(18). 4922–4930. 9 indexed citations
7.
Rowbottom, Martin W., Brian Dyck, Mingzhu Zhang, et al.. (2006). Synthesis and structure–activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1. Bioorganic & Medicinal Chemistry Letters. 16(17). 4450–4457. 6 indexed citations
8.
Dyck, Brian, Joseph Pontillo, Christopher E. Heise, et al.. (2006). Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(16). 4237–4242. 14 indexed citations
9.
Schwarz, David, Robert E. Petroski, Jordan E. Pomeroy, et al.. (2006). Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function. Molecular and Cellular Endocrinology. 259(1-2). 1–9. 1 indexed citations
10.
Huang, Charles Q., Tracy J. Baker, David Schwarz, et al.. (2005). 1-(4-Amino-phenyl)-pyrrolidin-3-yl-amine and 6-(3-amino-pyrrolidin-1-yl)-pyridin-3-yl-amine derivatives as melanin-concentrating hormone receptor-1 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(16). 3701–3706. 28 indexed citations
11.
Tucci, Fábio C., Stacy Markison, Margaret Joppa, et al.. (2005). Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines. Bioorganic & Medicinal Chemistry Letters. 15(19). 4389–4395. 30 indexed citations
12.
Dyck, Brian, Martin W. Rowbottom, Mingzhu Zhang, et al.. (2005). Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 999–1004. 20 indexed citations
13.
Dyck, Brian, Val S. Goodfellow, Teresa A. Phillips, et al.. (2004). Potent imidazole and triazole CB 1 receptor antagonists related to SR141716. Bioorganic & Medicinal Chemistry Letters. 14(5). 1151–1154. 56 indexed citations
14.
Phillips, Teresa A., et al.. (2004). Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Research. 1000(1-2). 64–71. 28 indexed citations
15.
Dyck, Brian, Val S. Goodfellow, Teresa A. Phillips, et al.. (2004). Potent Imidazole and Triazole CB1 Receptor Antagonists Related to SR141716.. ChemInform. 35(25). 4 indexed citations
16.
Dyck, Brian, Jessica Parker, Teresa Phillips, et al.. (2003). Aryl piperazine melanocortin MC4 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 13(21). 3793–3796. 40 indexed citations
17.
Goodfellow, Val S. & John Saunders. (2003). The Melanocortin System and its Role in Obesity and Cachexia. Current Topics in Medicinal Chemistry. 3(8). 855–883. 36 indexed citations
18.
Foster, Alan C., Margaret Joppa, Stacy Markison, et al.. (2003). Body Weight Regulation by Selective MC4 Receptor Agonists and Antagonists. Annals of the New York Academy of Sciences. 994(1). 103–110. 21 indexed citations
19.
Wieczorek, Maciej, Michael Burkard, John S. Zuzack, et al.. (1997). Bradykinin antagonists in human systems: Correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum. Biochemical Pharmacology. 54(2). 283–291. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yousang Hwang Breakdown of academic impact, for papers by Lihu Yang Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Feroze Ujjainwalla Breakdown of academic impact, for papers by Barbara J. Palazuk Breakdown of academic impact, for papers by K. A. NEWLANDER Breakdown of academic impact, for papers by Jinhai Gao Breakdown of academic impact, for papers by Gene F. Tutwiler Breakdown of academic impact, for papers by Janet Cheetham Breakdown of academic impact, for papers by Huiqiang Zhou
Rankless by CCL
2026